Proteintech Selects AWS, Launches Industry's First AI Antibody Assistant

Details

• Proteintech named AWS as its preferred cloud provider and launched Able, the industry's first AI-powered antibody assistant to help researchers with product selection and experimental design.
• 85% of Proteintech's workloads are now hosted on AWS, streamlining global operations and ensuring robust data security.
• The Able assistant runs on a suite of AWS services, including EC2, ECS, RDS, and Redshift, enabling rapid data analysis and real-time research support.
• Development of Able was completed in just six months, slashing Proteintech's typical launch timelines by 50%.
• Leveraging Proteintech's proprietary validation data and experimental archives, Able delivers tailored product recommendations, helping researchers reduce trial-and-error in antibody selection.

Impact

Proteintech's swift rollout of Able AI positions it at the forefront of AI-driven laboratory tools, capturing a first-mover advantage as competitors like Abcam and Thermo Fisher ramp up their digital offerings. This move underscores AWS's expanding reach in life sciences and highlights a growing industry pivot toward automation and generative AI in research workflows.